FILTER
Prikaži samo sadržaje koji zadovoljavaju:
objavljeni u periodu:
na jeziku:
hrvatski engleski
sadrže pojam:

Pliva finishes sale of Sanctura drug

ZAGREB, July 4 (Hina) - The leading Croatian pharmaceutical companyPliva has wrapped up the sale of its Sanctura drug to the EspritPharma Holding Company, reads a press release which Pliva sent to theZagreb Stock Exchange.
ZAGREB, July 4 (Hina) - The leading Croatian pharmaceutical company Pliva has wrapped up the sale of its Sanctura drug to the Esprit Pharma Holding Company, reads a press release which Pliva sent to the Zagreb Stock Exchange.

Upon the completion of the transaction, Pliva received 45 million US dollars from Esprit, and is entitled to additional sums up to 95 million dollars which are linked to the accomplishment of four goals in the sale.

This transaction will lead to the decrease of Pliva's book value by 93 million dollars in the second quarter of this year.

VEZANE OBJAVE

An unhandled error has occurred. Reload 🗙